Format

Send to

Choose Destination
See comment in PubMed Commons below
ALTEX. 2014;31(4):500-19. doi: http://dx.doi.org/10.14573/altex.1401281. Epub 2014 Jan 28.

Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action.

Author information

1
The Humane Society of the United States.

Abstract

A workshop sponsored by the Human Toxicology Project Consortium (HTPC), "Building Shared Experience to Advance Practical Application of Pathway-Based Toxicology: Liver Toxicity Mode-of-Action" brought together experts from a wide range of perspectives to inform the process of pathway development and to advance two prototype pathways initially developed by the European Commission Joint Research Center (JRC): liver-specific fibrosis and steatosis. The first half of the workshop focused on the theory and practice of pathway development; the second on liver disease and the two prototype pathways. Participants agreed pathway development is extremely useful for organizing information and found that focusing the theoretical discussion on a specific AOP is extremely helpful. In addition, it is important to include several perspectives during pathway development, including information specialists, pathologists, human health and environmental risk assessors, and chemical and product manufacturers, to ensure the biology is well captured and end use is considered.

[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Spektrum Akademischer Verlag Icon for PubMed Central
    Loading ...
    Support Center